Appendix: Representative Compounds With Inhibitory Activity Against SARS CoV or Other CoVs in Vitro

doi 10.1002/9780470755952.app1
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Blackwell Publishing Ltd

Related search

FDA Approved Drugs With Broad Anti-Coronaviral Activity Inhibit SARS-CoV-2 in Vitro

2020English

Study on Structure–activity Relationships (SARs) of Epoxylignan Compounds With Α- Glucosidase Inhibitory Activity

Science and Technology Development Journal - Natural Sciences
2018English

Detection of Antibodies Against SARS-CoV-2 in Patients With COVID-19

Journal of Medical Virology
VirologyInfectious Diseases
2020English

Virus Against Virus: A Potential Treatment for 2019-nCov (SARS-CoV-2) and Other RNA Viruses

Cell Research
Cell BiologyMolecular Biology
2020English

Fully Human Single-Domain Antibodies Against SARS-CoV-2

2020English

In Vitro Activity of MK0787 (N-Formimidoyl Thienamycin) and Other Beta-Lactam Compounds Against Bacteroides Spp.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1981English

In-Depth Bioinformatic Analyses of Human SARS-CoV-2, SARS-CoV, MERS-CoV, and Other Nidovirales Suggest Important Roles of Noncanonical Nucleic Acid Structures in Their Lifecycles

2020English

Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection

JAMA - Journal of the American Medical Association
Medicine
2020English

In Vitro Inhibitory Activity of Essential Oil Vapors Against Ascosphaera Apis

Natural Product Communications
PharmacologyComplementaryPlant ScienceAlternative MedicineMedicineDrug Discovery
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy